Neue Medikamente zur Behandlung der Obstipation
- 30 July 2010
- journal article
- Published by Springer Nature in Medizinische Klinik
- Vol. 105 (7) , 475-478
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Efficacy and Safety of Lubiprostone in Patients with Chronic ConstipationDigestive Diseases and Sciences, 2009
- Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studiesAlimentary Pharmacology & Therapeutics, 2008
- Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2008
- Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxativesGut, 2008
- Clinical trial: renzapride therapy for constipation‐predominant irritable bowel syndrome – multicentre, randomized, placebo‐controlled, double‐blind study in primary healthcare settingAlimentary Pharmacology & Therapeutics, 2008
- The Cardiovascular Safety Profile of Renzapride, a Novel Treatment for Irritable Bowel SyndromeJournal of International Medical Research, 2007
- Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation‐predominant irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2006
- Prucalopride Is Effective in Patients with Severe Chronic Constipation in Whom Laxatives Fail to Provide Adequate ReliefDigestion, 2003
- Prokinetic agents for lower gastrointestinal motility disordersDiseases of the Colon & Rectum, 1993
- LONG-TERM FOLLOW-UP OF TARDIVE DYSKINESIA DUE TO METOCLOPRAMIDEThe Lancet, 1982